Editorial
Men’s health: a rapidly changing landscape of healthcare delivery and treatment
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S114-S115
.
(05 March 2020)
Review Article
Current and future trends in men’s health clinics
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S116-S122
.
(05 March 2020)
A review of the evolving landscape between the consumer Internet and men’s health
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S123-S134
.
(05 March 2020)
Selective androgen receptor modulators: the future of androgen therapy?
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S135-S148
.
(05 March 2020)
Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S149-S159
.
(05 March 2020)
Non-testosterone management of male hypogonadism: an examination of the existing literature
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S160-S170
.
(05 March 2020)
New frontiers in fertility preservation: a hypothesis on fertility optimization in men with hypergonadotrophic hypogonadism
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S171-S177
.
(05 March 2020)
The effect of sleep on men’s health
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S178-S185
.
(05 March 2020)
Nandrolone decanoate relieves joint pain in hypogonadal men: a novel prospective pilot study and review of the literature
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S186-S194
.
(05 March 2020)
Future diagnostics in male infertility: genomics, epigenetics, metabolomics and proteomics
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S195-S205
.
(05 March 2020)
Towards a better testicular sperm extraction: novel sperm sorting technologies for non-motile sperm extracted by microdissection TESE
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S206-S214
.
(05 March 2020)
Fertility preservation options for transgender individuals
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S215-S226
.
(05 March 2020)
Oncofertility in adult and pediatric populations: options and barriers
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S227-S238
.
(05 March 2020)
Comprehensive men’s health and male infertility
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S239-S243
.
(05 March 2020)
Perspective
The future of penile prostheses for the treatment of erectile dysfunction
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S244-S251
.
(05 March 2020)
Review Article
The good, bad, and the ugly of regenerative therapies for erectile dysfunction
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S252-S261
.
(05 March 2020)
Peyronie’s disease: is it genetic or not?
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S262-S268
.
(05 March 2020)
Minimally invasive therapies for Peyronie’s disease: the current state of the art
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S269-S283
.
(05 March 2020)
Evolving therapies for Peyronie’s disease: how can we work towards new drugs?
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S284-S294
.
(05 March 2020)
Original Article
Non-conventional therapies for Peyronie’s disease: what is the evidence for efficacy?
Translational Andrology and Urology
2020;
9
(Suppl 2)
:S295-S302
.
(05 March 2020)
Disclosure:
The supplement “Contemporary Issues and Controversies in Men’s Health” was commissioned by the editorial office, Translational Andrology and Urology without any sponsorship or funding. Larry I. Lipshultz and Alexander W. Pastuszak served as the unpaid Guest Editors for the supplement.
